Wordt geladen...

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus

OBJECTIVE: It is known that patients with diabetes are susceptible to cancer development due to long-standing diabetic conditions. This study aimed to investigate new-onset cancer risk associated with dipeptidyl peptidase-4 (DPP-4) inhibitors as compared to metformin, the first-line antidiabetic age...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Manag Res
Hoofdauteurs: Choi, Yeo Jin, Kim, Dae Jung, Shin, Sooyoung
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove 2019
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689554/
https://ncbi.nlm.nih.gov/pubmed/31496802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S215107
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!